The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis.
Saar T HalperinBert A 't HartAntonio LuchicchiGeert J SchenkPublished in: Biomedicines (2022)
Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system (CNS), traditionally considered a chronic autoimmune attack against the insulating myelin sheaths around axons. However, the exact etiology has not been identified and is likely multi-factorial. Recently, evidence has been accumulating that implies that autoimmune processes underlying MS may, in fact, be triggered by pathological processes initiated within the CNS. This review focuses on a relatively unexplored immune cell-the "innate-like" B1 lymphocyte. The B1 cell is a primary-natural-antibody- and anti-inflammatory-cytokine-producing cell present in the healthy brain. It has been recently shown that its frequency and function may differ between MS patients and healthy controls, but its exact involvement in the MS pathogenic process remains obscure. In this review, we propose that this enigmatic cell may play a more prominent role in MS pathology than ever imagined. We aim to shed light on the human B1 cell in health and disease, and how dysregulation in its delicate homeostatic role could impact MS. Furthermore, novel therapeutic avenues to restore B1 cells' beneficial functions will be proposed.
Keyphrases
- multiple sclerosis
- white matter
- mass spectrometry
- ms ms
- immune response
- end stage renal disease
- healthcare
- single cell
- chronic kidney disease
- endothelial cells
- blood brain barrier
- cell therapy
- newly diagnosed
- public health
- stem cells
- ejection fraction
- density functional theory
- peripheral blood
- prognostic factors
- brain injury
- bone marrow
- patient reported